| Conferences \ Advances in Drug Discovery \ Stem Cells in Drug Discovery \ Agenda \ Mark Hewitson |
| Register | Login |
Human iPSC-derived Tissues as Novel Translational Models for Drug Discovery and ScreeningMonday, 6 March 2017 at 14:30  Add to Calendar ▼2017-03-06 14:30:002017-03-06 15:30:00Europe/LondonHuman iPSC-derived Tissues as Novel Translational Models for Drug Discovery and ScreeningSELECTBIOenquiries@selectbiosciences.comHuman cell types differentiated from induced pluripotent stem cells (iPSCs) offer an attractive source of cellular material for both toxicity screening and drug discovery because of the biologically relevant systems they can represent in vitro. The iPSC technology is a key element for modeling human biology in a dish, which is otherwise difficult to explore using conventional cell lines, primary cells, or animal models. Our approach is to generate iPSC-derived cell types with high quality, purity, and unlimited quantities, design relevant assays with cells derived from apparently healthy donors, and develop disease models using environmental stimuli or disease-specific, patient-derived cells. Current efforts are aimed at generating large iPSC clone banks from diverse diseased backgrounds that will serve to dramatically expand access to cell models offering new tools and opportunities for phenotypic drug discovery. |
Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonStem Cells in Drug DiscoverySELECTBIOenquiries@selectbiosciences.com
.gif){kind=logo}
